Accordingly, we observed decreased CD4+ /CD8+ T cell ratios in cancer patients’ PBMCs, suggesting an overall increase in the CD8+ T cell subset in cancer patients when compared to healthy individuals (Fig. 3C). Here, CD8A is linked to cancer.